Democritus University of Thrace (DUTH)
Πληθυσμοί και υποπληθυσμοί κυττάρων του BAL σε ασθενείς με καρκίνο πνεύμονος, προ και μετά χημειοθεραπείας
Abstract
dc:descriptionBackground: Reports point out lung toxicity of chemotherapeutic agents and/or radiation therapy in lung cancer patients. However these studies usually concern the lung with the primary tumor and little is known about the “healthy” lung parenchyma. The aim of our study was to assess T-lymphocytes subpopulations in BAL of patients with metastatic lung cancer who treated with the three most applied platinum-based regimens at the level of the lung without the primary tumor. Furthermore, histological and lung function changes were evaluated after sequential chemoradiation.Methods: Fifteen lung cancer patients participated the study and underwent BAL of the opposite to the tumor lung, during diagnostic bronchoscopy before and after sequential treatment of chemotherapy with the 3 most applied platinum-based combinations: of vinorelbine (VN) 6 patients, gemcitabine (GEM) 4 patients and etoposide (EP) 5 patients and radiation therapy. Lung function tests, before and after sequential treatment, were forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), total lung capacity (TLC), diffusing capacity for carbon monoxide (DLCO) and carbon monoxide transfer coefficient (Kco).Results: Mean patients’ age was 58±9.4 years (42–75 years). Male patients were 14 (93.3%), all smokers. No significant changes in CD4+ and CD8+ cells were noted between the 3 groups of treatment. However, changes were noted within each group only for CD4+ cells: VN before vs after p= 0.05; GEM before vs after p=0.03; EP before vs after p=0.3. For CD8+ no significant changes were noted. Overall, after chemoradiation treatment significant changes were noted in FEV1 (P=0.012), FVC (P=0.046), TLC (P=0.04) from baseline. The drop from baseline was more significant after chemoradiation therapy in DLCO (P=0.002) and KCO (P=0.008). When adjusted to the treatment group, this decline of PFTs was only observed with the combination of cisplatin and GEMConclusions: According to our results, changes were noted in BALF CD4+ cells for the 3 most applied-platinum based combinations. Sequential chemoradiation causes significant changes in lung function parameters in patients with lung cancer.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- michailidis, vasileios
- Μιχαηλίδης, Βασίλειος
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44796